benzimidazole has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HS | 1 |
| Ko, YS | 1 |
| Jin, H | 1 |
| Kang, KM | 1 |
| Ha, IB | 1 |
| Jeong, H | 1 |
| Song, HN | 1 |
| Kim, HJ | 1 |
| Jeong, BK | 1 |
| Qian, Y | 1 |
| Zhang, J | 1 |
| Xu, R | 1 |
| Li, Q | 1 |
| Shen, Q | 1 |
| Zhu, G | 1 |
| Wang, M | 1 |
| Wu, Y | 1 |
| Xu, C | 1 |
| Zhao, R | 1 |
| Huang, Y | 1 |
| Zeng, X | 1 |
| Chen, T | 1 |
3 other studies available for benzimidazole and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Line | 2021 |
Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; beta-Cyclodextrins; Cell Line, Tumor; Cell Movement; | 2021 |
Design and Synthesis of 2-(5-Phenylindol-3-yl)benzimidazole Derivatives with Antiproliferative Effects towards Triple-Negative Breast Cancer Cells by Activation of ROS-Mediated Mitochondria Dysfunction.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Des | 2019 |